Jane Street
BCTX

Jane Street’s Briacell Therapeutics BCTX Stock Holding History

Jane Street’s Portfolio BCTX Stock Details BCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-537
Closed -$817K – 9649
2022
Q1 		$817K Sell
537
-946
-64% -$1.12M ﹤0.01% 6540
2021
Q4 		$1.84M Buy
+1,483
New +$1.94M ﹤0.01% 4639

Other funds holding BCTX

CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
LCM
LuminArx Capital Management New York $224M AUM
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Jane Street's BCTX Position: Q2 2026 in Review

Jane Street opened a new position in Briacell Therapeutics (BCTX) in Q2 2026: 26,515 shares worth $85.9K. The stake represents ﹤0.01% of the portfolio and ranks #10679 among its holdings. This is a return to the name: Jane Street previously reported a position in BCTX as recently as Q4 2024.

Jane Street first reported a position in BCTX in Q3 2021 and has held it in 5 quarters since. The position peaked at $546K in Q3 2022. 19 funds tracked by Wall St. Rank hold BCTX as of Q2 2026.

  • Jane Street held 26,515 shares of Briacell Therapeutics worth $85.9K as of Q2 2026.
  • Briacell Therapeutics was a new Jane Street position in Q2 2026.
  • Briacell Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10679 holding.
  • Jane Street first reported a position in Briacell Therapeutics in Q3 2021 and has held it in 5 quarters since.
  • Jane Street's Briacell Therapeutics position peaked at $546K in Q3 2022.
  • 19 funds tracked by Wall St. Rank held Briacell Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.